| Date Filed | Type | Description |
| 01/10/2023 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 67,070 options to buy
@ $23.23, valued at
$1.6M
Granted 24,580 restricted stock units
@ $0 |
|
| 09/16/2022 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 12,000 restricted stock units
@ $0 |
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 70,000 options to buy
@ $30.44, valued at
$2.1M
|
|
| 11/17/2021 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 964 shares
@ $22.03, valued at
$21.2k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 14,904 options to buy
@ $2.32, valued at
$34.6k
Granted 22,500 options to buy
@ $2.32, valued at
$52.2k
|
|
| 06/04/2018 |
4
| Lizzul Paul F. (Chief Medical Officer) has filed a Form 4 on Sienna Biopharmaceuticals, Inc.|
Txns:
| Granted 48,720 options to buy
@ $15.08, valued at
$734.7k
|
|
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |